MASScot does not endorse nor is affiliated with any of the content contained within these links.
- Study: Telomere length impacts melanoma risk
Researchers with Dartmouth College have found that genes controlling telomere length of telomeres influence the risk of melanoma.
Source: Dermatology Times
- GSK melanoma pill backed by UK cost watchdog with price cut
Britain's healthcare cost agency NICE has recommended a third new drug for melanoma, this time from GlaxoSmithKline, after the drugmaker offered to supply it at a discount to the state-run National Health Service.
Source: Reuters
- New melanoma treatment approved by NICE
Dabrafenib will be the second melanoma drug targeting the BRAF V600 mutation to be available on the NHS after NICE approved vemurafenib in December 2012.
Source: Pharmaceutical Journal
- 'A single mole caused cancer to spread through my body - now I only have months to live': Horror of man, 24, whose holiday sunburn led to life-threatening disease
A man has been given just months to live after learning a mole he developed while on holiday was in fact a rare form of cancer that has spread through his inner organs.
Source: Daily Mail
- Melanoma Could Be Caused By Ageing Genes; Best Diet For Anti-Ageing; Celebrities Who Have Aged Gracefully
A recent study by an international team of researchers found that ageing genes could play a role in melanoma, a type of skin cancer. It was found that genes that have the ability to control the length of telomeres, the caps at the end of the chromosomes, could be related to melanoma susceptability.
Source: ibtimes
- I thought I could beat anything. Then my doctor said: 'You have skin cancer': Bestselling author relives the most harrowing moment of her life
Bestselling author of Second Chance relives her most harrowing moment. Jane Green knew there was a risk as skin cancer ran in the family. She tells of the agonising wait to find out if the disease had spread.
Source: Daily Mail
- Melanoma Institute’s groundbreaking cancer treatment gives Craig Lawn new lease on life
THERE is a high chance Craig Lawn would not be alive today if not for a world-first drugs trial which is revolutionising treatment for melanoma. In November last year, Mr Lawn was given six months to live after being diagnosed with inoperable, stage four melanoma.
Source: Daily Telegraph AU
- Skin cancer drug should be available on NHS, officials say
A new drug for skin cancer patients should be made widely available on the NHS, health officials have said.
Dabrafenib can have a "rapid positive effect" on patients with a certain type of melanoma, the National Institute for Health and Care Excellence (Nice) said.
- Removing your tattoo 'can give you skin cancer'... and is almost as dangerous as tanning beds
Removing your tattoo increases the risk of skin cancer and is as dangerous as lying on a tanning bed, according to an expert. Dr Ian McDougall, based on the Gold Coast Queensland, believes not enough information is given to patients who undergo the procedure and said the industry should be better regulated.
- Calming down immune cells could hold key to melanoma treatment
Cancer Research UK scientists at The University of Manchester found that chemical signals produced by a type of immune cell, called macrophages, also act as a survival signal for melanoma cells.
Source: Cancer Research UK